OrganiGram Holdings Inc (OGI)
1.51
+0.01
(+0.67%)
USD |
NASDAQ |
Nov 29, 16:00
1.55
+0.04
(+2.65%)
After-Hours: 07:55
OrganiGram Holdings Revenue (Quarterly): 30.00M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 30.00M |
| March 31, 2024 | 27.90M |
| December 31, 2023 | 26.78M |
| May 31, 2023 | 24.13M |
| February 28, 2023 | 29.27M |
| November 30, 2022 | 32.12M |
| August 31, 2022 | 35.24M |
| May 31, 2022 | 29.95M |
| February 28, 2022 | 25.03M |
| November 30, 2021 | 24.18M |
| August 31, 2021 | 19.97M |
| May 31, 2021 | 16.39M |
| February 28, 2021 | 11.48M |
| November 30, 2020 | 14.68M |
| August 31, 2020 | 15.17M |
| May 31, 2020 | 12.88M |
| February 29, 2020 | 17.63M |
| November 30, 2019 | 19.02M |
| August 31, 2019 | 12.32M |
| Date | Value |
|---|---|
| May 31, 2019 | 18.46M |
| February 28, 2019 | 20.21M |
| November 30, 2018 | 9.508M |
| August 31, 2018 | 2.440M |
| May 31, 2018 | 2.674M |
| February 28, 2018 | 2.696M |
| November 30, 2017 | 1.908M |
| August 31, 2017 | 1.416M |
| May 31, 2017 | 1.422M |
| February 28, 2017 | -0.4393M |
| November 30, 2016 | 1.683M |
| August 31, 2016 | 1.438M |
| May 31, 2016 | 1.390M |
| February 29, 2016 | 1.025M |
| November 30, 2015 | 0.7796M |
| August 31, 2015 | 0.5284M |
| May 31, 2015 | 0.1858M |
| February 28, 2015 | 0.0566M |
| November 30, 2014 | 0.0117M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
11.48M
Minimum
Feb 2021
35.24M
Maximum
Aug 2022
23.11M
Average
24.18M
Median
Nov 2021
Revenue (Quarterly) Benchmarks
| Tilray Brands Inc | 200.04M |
| Aurinia Pharmaceuticals Inc | 67.77M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.084M |
| Xenon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.059M |
| Total Expenses (Quarterly) | 33.69M |
| EPS Diluted (Quarterly) | 0.019 |
| Enterprise Value | 97.97M |
| Gross Profit Margin (Quarterly) | 34.12% |
| Profit Margin (Quarterly) | 6.86% |
| Earnings Yield | -55.76% |
| Normalized Earnings Yield | 58.82 |